Deferred Tax Assets, Valuation Allowance of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Intra-Cellular Therapies, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $297,449,000, a 9.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $297,449,000 +$26,860,000 +9.9% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q4 2023 $270,589,000 +$50,275,000 +23% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $220,314,000 +$53,741,000 +32% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $166,573,000 +$53,282,318 +47% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $113,290,682 +$39,953,621 +54% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $73,337,061 +$8,310,715 +13% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $65,026,346 +$5,013,286 +8.4% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $60,013,060 -$10,989,941 -15% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $71,003,001 -$19,605,520 -22% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q4 2015 $90,608,521 +$51,165,860 +130% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q4 2014 $39,442,661 +$14,655,318 +59% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q4 2013 $24,787,343 +$13,229,355 +114% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 $11,557,988 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.